5HL-14705-91891
2 vaccinations
2 coded responses
18 check-ins
2 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 265 / WV
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-15
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Registered in v-safe
-
2020-12-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-17
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-18
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-22
- 2020-12-22
- 2020-12-29
- 2021-01-05
-
2021-01-06
Dose 2 — Pfizer-BioNTech
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-01-07
- 2021-01-09
- 2021-01-15
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-17
Survey response — day 42, dose 2MedDRA: Oral herpes, Rash, Specialist consultation — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: I have developed a rash believed to be pityriasis rosea. Interestingly enough, prior to the rash I had the worst cold sore of my life about 2 weeks after getting the vaccine. Both are thought to be immune related, possibly to the vaccine but unclear. · Healthcare visit (other): DermatologistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-07
Survey response — 3 months, dose 2MedDRA: Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Approx 2 weeks after my second dose, I developed a very significant full body rash that lasted approximately 1 month. This required a visit to a dermatologist who determined it was likely vaccine related. It finally resolved and is now mostly gone. · Healthcare visit (other): In person visit to dermatologistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-31
Call successfulCompleted over the phone
-
2021-05-31
Call successfulCompleted over the phone
- 2021-07-07
- 2022-01-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-15 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech |
Call center
4 call center cases
4 successful
VAERS report filed, before or during a call: 4
Free text
Release 4 — day 42, dose 2
Symptoms: I have developed a rash believed to be pityriasis rosea. Interestingly enough, prior to the rash I had the worst cold sore of my life about 2 weeks after getting the vaccine. Both are thought to be immune related, possibly to the vaccine but unclear. cut off by CDC
Healthcare visit (other): Dermatologist
Release 7 — 3 months, dose 2
Symptoms: Approx 2 weeks after my second dose, I developed a very significant full body rash that lasted approximately 1 month. This required a visit to a dermatologist who determined it was likely vaccine related. It finally resolved and is now mostly gone. cut off by CDC
Healthcare visit (other): In person visit to dermatologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Specialist consultation | ✓ | ✓ | ✓ |
| SD | Oral herpes | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release